| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |